Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 07, 2017 16:05 ET | Source: OpGen, Inc.

OpGen Reports 2017 Third Quarter Financial Results and Provides Business Update

Affirms plans to release Acuitas® AMR Gene Panel in the first quarter of 2018 Conference call begins at 4:30 p.m. Eastern time today GAITHERSBURG, Md., Nov. 07, 2017 (GLOBE NEWSWIRE) -- OpGen,...
October 26, 2017 16:00 ET | Source: OpGen, Inc.

OpGen Announces Date of Third Quarter 2017 Financial Results Conference Call

GAITHERSBURG, Md., Oct. 26, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that it will report its third quarter 2017 financial results after close of market on Tuesday, November...
October 23, 2017 11:00 ET | Source: OpGen, Inc.

OpGen Awarded CDC Contract to Develop Clinical Support Tools for Antimicrobial Stewardship and Infection Control

GAITHERSBURG, Md., Oct. 23, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that it has been awarded a contract from the Centers for Disease Control and Prevention (CDC) to...
October 13, 2017 07:30 ET | Source: OpGen, Inc.

OpGen to Present at Dawson James Securities 3rd Annual Small Cap Growth Conference

GAITHERSBURG, Md., Oct. 13, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that Evan Jones, the Company’s Chairman and Chief Executive Officer, will present a corporate overview...
September 20, 2017 07:30 ET | Source: OpGen, Inc.

OpGen to Present at the Ladenburg Thalmann 2017 Healthcare Conference

GAITHERSBURG, Md., Sept. 20, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that Evan Jones, the Company’s Chairman and Chief Executive Officer, will present a corporate overview...
September 08, 2017 07:30 ET | Source: OpGen, Inc.

OpGen Data on New Rapid Gene Test and Antibiotic Susceptibility Prediction Algorithms Presented at the 2017 ASM/ESCMID Conference

GAITHERSBURG, Md., Sept. 08, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that the Company presented study results on the company’s new rapid test in development, the Acuitas®...
September 06, 2017 09:00 ET | Source: OpGen, Inc.

OpGen to Present at the Rodman & Renshaw 19th Annual Global Investment Conference

GAITHERSBURG, Md., Sept. 06, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that Evan Jones, the Company’s Chairman and Chief Executive Officer, will present a corporate overview...
August 08, 2017 16:01 ET | Source: OpGen, Inc.

OpGen Reports 2017 Second Quarter Financial Results and Provides Business Update

Affirms plans to launch first Acuitas® Rapid Test in first half of 2018 Conference call begins at 4:30 p.m. Eastern time today GAITHERSBURG, Md., Aug. 08, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc....
August 02, 2017 07:30 ET | Source: OpGen, Inc.

OpGen Announces Date of Second Quarter 2017 Financial Results Conference Call

GAITHERSBURG, Md., Aug. 02, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that it will report its second quarter 2017 financial results after close of market on Tuesday, August...
July 19, 2017 09:25 ET | Source: OpGen, Inc.

OpGen Announces Closing of $10 Million Public Offering

GAITHERSBURG, Md., July 19, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) announces the closing of its previously announced public offering of 18,164,195 units at $0.40 per unit, and 6,835,805...